Cargando…

Corrigendum: MRI radiomics predicts progression-free survival in prostate cancer

Detalles Bibliográficos
Autores principales:	Jia, Yushan, Quan, Shuai, Ren, Jialiang, Wu, Hui, Liu, Aishi, Gao, Yang, Hao, Fene, Yang, Zhenxing, Zhang, Tong, Hu, He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880521/ https://www.ncbi.nlm.nih.gov/pubmed/36713503 http://dx.doi.org/10.3389/fonc.2022.1125641

Ejemplares similares

MRI radiomics predicts progression-free survival in prostate cancer
por: Jia, Yushan, et al.
Publicado: (2022)

Multiparameter MRI Radiomics Model Predicts Preoperative Peritoneal Carcinomatosis in Ovarian Cancer
por: Yu, Xiao Yu, et al.
Publicado: (2021)

Efficacy and safety of radiofrequency ablation and surgery for hepatocellular carcinoma in patients with cirrhosis: A meta-analysis
por: Zhang, Tong, et al.
Publicado: (2022)

Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
por: Ye, Shuai, et al.
Publicado: (2023)

Predicting Progression-Free Survival Using MRI-Based Radiomics for Patients With Nonmetastatic Nasopharyngeal Carcinoma
por: Shen, Hesong, et al.
Publicado: (2020)

Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021)

The clinical guiding value of a radiomics model for androgen deprivation therapy for prostate cancer
por: Yu, Na, et al.
Publicado: (2021)

MRI Radiomic Features: A Potential Biomarker for Progression-Free Survival Prediction of Patients With Locally Advanced Cervical Cancer Undergoing Surgery
por: Cai, Mengting, et al.
Publicado: (2021)

Development and validation of a preoperative MRI-based radiomics nomogram to predict progression-free survival in patients with clival chordomas
por: Zhai, Yixuan, et al.
Publicado: (2022)

Prediction of Locoregional Recurrence-Free Survival of Oesophageal Squamous Cell Carcinoma After Chemoradiotherapy Based on an Enhanced CT-Based Radiomics Model
por: Kong, Jie, et al.
Publicado: (2021)

Establishment and validation of novel MRI radiomic feature-based prognostic models to predict progression-free survival in locally advanced rectal cancer
por: Xie, Fei, et al.
Publicado: (2022)

MRI Radiomics in Prostate Cancer: A Reliability Study
por: Urraro, Fabrizio, et al.
Publicado: (2021)

Corrigendum: Contrast-Enhanced CT-Based Radiomics Analysis in Predicting Lymphovascular Invasion in Esophageal Squamous Cell Carcinoma
por: Li, Yang, et al.
Publicado: (2021)

Evaluation of the Efficiency of MRI-Based Radiomics Classifiers in the Diagnosis of Prostate Lesions
por: Li, Linghao, et al.
Publicado: (2022)

Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy
por: Ye, Shuai, et al.
Publicado: (2022)

Radiomics Analysis of Multiparametric MRI for the Preoperative Prediction of Lymph Node Metastasis in Cervical Cancer
por: Hou, Lina, et al.
Publicado: (2020)

Multi-Parameter MR Radiomics Based Model to Predict 5-Year Progression-Free Survival in Endometrial Cancer
por: Liu, Defeng, et al.
Publicado: (2022)

Predicting Disease-Free Survival With Multiparametric MRI-Derived Radiomic Signature in Cervical Cancer Patients Underwent CCRT
por: Liu, Bing, et al.
Publicado: (2022)

Advanced Imaging of Biochemical Recurrent Prostate Cancer With PET, MRI, and Radiomics
por: Shaikh, Faiq, et al.
Publicado: (2020)

Dynamic contrast-enhanced magnetic resonance imaging-based radiomics for the prediction of progression-free survival in advanced nasopharyngeal carcinoma
por: Li, Wen-zhu, et al.
Publicado: (2022)

MRI-Based Bone Marrow Radiomics Nomogram for Prediction of Overall Survival in Patients With Multiple Myeloma
por: Li, Yang, et al.
Publicado: (2021)

Development and Validation of a CT-Based Radiomics Nomogram for Predicting Postoperative Progression-Free Survival in Stage I–III Renal Cell Carcinoma
por: Zhang, Haijie, et al.
Publicado: (2022)

Multi-view radiomics and deep learning modeling for prostate cancer detection based on multi-parametric MRI
por: Li, Chunyu, et al.
Publicado: (2023)

MRI-Derived Radiomics to Guide Post-operative Management for High-Risk Prostate Cancer
por: Bourbonne, Vincent, et al.
Publicado: (2019)

Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram
por: Jing, Guodong, et al.
Publicado: (2022)

MRI Based Radiomics Compared With the PI-RADS V2.1 in the Prediction of Clinically Significant Prostate Cancer: Biparametric vs Multiparametric MRI
por: Chen, Tong, et al.
Publicado: (2022)

A Multiparametric MRI-Based Radiomics Nomogram for Preoperative Prediction of Survival Stratification in Glioblastoma Patients With Standard Treatment
por: Jia, Xin, et al.
Publicado: (2022)

Radiomics of Multiparametric MRI to Predict Biochemical Recurrence of Localized Prostate Cancer After Radiation Therapy
por: Zhong, Qiu-Zi, et al.
Publicado: (2020)

MRI radiomics and potential applications to glioblastoma
por: Hooper, Grayson W., et al.
Publicado: (2023)

Machine-Learning-Derived Nomogram Based on 3D Radiomic Features and Clinical Factors Predicts Progression-Free Survival in Lung Adenocarcinoma
por: Liu, Guixue, et al.
Publicado: (2021)

A Clinical-Radiomics Nomogram Based on Magnetic Resonance Imaging for Predicting Progression-Free Survival After Induction Chemotherapy in Nasopharyngeal Carcinoma
por: Liu, Lu, et al.
Publicado: (2022)

Delta radiomics model for the prediction of progression-free survival time in advanced non-small-cell lung cancer patients after immunotherapy
por: Xie, Dong, et al.
Publicado: (2022)

Ultrasound-Based Radiomics Analysis for Predicting Disease-Free Survival of Invasive Breast Cancer
por: Xiong, Lang, et al.
Publicado: (2021)

An exploratory study of CT radiomics using differential network feature selection for WHO/ISUP grading and progression-free survival prediction of clear cell renal cell carcinoma
por: Yin, Fu, et al.
Publicado: (2022)

Predicting the Grade of Prostate Cancer Based on a Biparametric MRI Radiomics Signature
por: Zhang, Li, et al.
Publicado: (2021)

Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis
por: Yang, Yin, et al.
Publicado: (2022)

Radiomic Machine Learning and External Validation Based on 3.0 T mpMRI for Prediction of Intraductal Carcinoma of Prostate With Different Proportion
por: Yang, Ling, et al.
Publicado: (2022)

Editorial: Radiomics in prostate cancer imaging
por: Brunese, Luca, et al.
Publicado: (2022)

The progress of radiomics in thyroid nodules
por: Gao, XiaoFan, et al.
Publicado: (2023)

Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer
por: Chen, Bihong T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_el47609r66i4h1od0k5jfso45s